SDF-1/CXCR4 signal is involved in decreased expression of p57kip2 in de novo MDS patients

References

• Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009;361:1872–85.
   PubMed Web of Science ®Google Scholar
• Pateras IS, Apostolopoulou K, Niforou K, Kotsinas A, Gorgoulis VG. p57kip2KIP2: ‘Kip’ing the cell under control. Mol Cancer Res. 2009;7:1902–19.
   PubMed Web of Science ®Google Scholar
• Economopoulou C, Pappa V, Papageorgiou S, Kontsioti F, Economopoulou P, Charitidou E, et al.. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS). Ann Hematol.2010;89:349–58.
   PubMed Web of Science ®Google Scholar
• Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14:159–69.
   PubMed Web of Science ®Google Scholar
• Kavanagh E, Joseph B. The hallmarks of CDKN1C (p57kip2, KIP2) in cancer. Biochim Biophys Acta. 2011;1816:50–6.
   PubMed Web of Science ®Google Scholar
• Guo H, Tian T, Nan K, Wang W. p57kip2: A multifunctional protein in cancer. Int J Oncol. 2010;36:1321–9.
   PubMed Web of Science ®Google Scholar
• Nie YC, Han YC, Zou YR. CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med. 2008;205:777–83.
   PubMed Web of Science ®Google Scholar
• Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 2010;16:2927–31.
   PubMed Web of Science ®Google Scholar
• Cashman J, Clark-Lewis I, Eaves A, Eaves C. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood. 2002;99:792–9.
   PubMed Web of Science ®Google Scholar
• Cashman J, Dykstra B, Clark-Lewis I, Eaves A, Eaves C. Changes in the proliferative activity of human he-matopoietic stem cells in NOD/SCID mice and enhancement of their transplantibility after in vivo treatment with cell cycle inhibitors. J Exp Med. 1996;196:1141–9.
   Web of Science ®Google Scholar
• Fuhler GM, Drayer AL, Olthof SG, Schuringa JJ, Coffer PJ, Vellenga E. Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell derived factor-1 induced migration of CD34+ cells from patients with myelodysplasia. Blood. 2008;111:359–68.
   PubMed Web of Science ®Google Scholar
• Kotsianidis I, Bouchliou I, Nakou E, Spanoudakis E, Margaritis D, Christophoridou AV, et al.. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia. 2009;23:510–8.
   PubMed Web of Science ®Google Scholar
• Chunkang C, Rui Y, Feng X, Juan G, Xi Z, Lingyun W, et al.. The roles of SDF-1/CXCR4 axis and its relationship with apoptosis in the myelodysplastic syndromes. Med Oncol. 2011;28:S494–500.
   PubMed Web of Science ®Google Scholar
• Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, et al.. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res. 2007;31:727–36.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292–302.
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al.. International scoring systemfor evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–88.
   PubMed Web of Science ®Google Scholar
• Bennett JM, Catovsky D, Daniel MT. Proposals for the classification of the acute leukaemias: French-American-British co-operative group. Br J Haematol. 1976;33:451–8.
   PubMed Web of Science ®Google Scholar
• Greenberg PL, Attar E, Bennett JM, Bloomfield CD, Castro DeCM, Deeg HJ, et al.. NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes. J Natl Compr Canc Netw. 2011;9:30–56.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, et al.. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 2006;108:419–25.
   PubMed Web of Science ®Google Scholar
• Guo J, Cai J, Yu L, Tang H, Chen C, Wang Z. EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo. Cancer Sci. 2011;102:530–9.
   PubMed Web of Science ®Google Scholar
• Wong AK, Fang B, Zhang L, Guo X, Lee S, Schreck R. Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia/myelodysplastic syndrome? Arch Pathol Lab Med. 2008;132:1329–32.
   PubMed Web of Science ®Google Scholar
• Park MT, Lee SJ. Cell cycle and cancer. J Biochem Mol Biol. 2003;36:60–5.
   PubMedGoogle Scholar
• Quesnel B, Guillerm G, Vereecque R, Wattel E, Preudhomme C, Bauters F, et al.. Methylation of the p15 (INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood. 1998;91:2985–90.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liégeois NJ, Wong C, Finegold M, Hou H, Thompson JC, et al.. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature. 1997;387:151–8.
   PubMed Web of Science ®Google Scholar
• Agool A, Schot BW, Jager PL, Vellenga E. 18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment. J Nucl Med. 2006;47:1592.
   PubMed Web of Science ®Google Scholar
• Bejar R, Levine R, Ebert BL. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J Clin Oncol. 2011;29:504–15.
   PubMed Web of Science ®Google Scholar
• Daskalakis M, Nguyen TT, Nguyen C, Guldberg P, Köhler G, Wijermans P, et al.. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine)treatment. Blood. 2002;100:2957–64.
   PubMed Web of Science ®Google Scholar
• Guyotat D, Campos L, Thomas X, Vila L, Shi ZH, Charrin C, et al.. Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns. Am J Hematol. 1990;34:26–31.
   PubMed Web of Science ®Google Scholar
• Oertel J, Huhn D. CD34 immunophenotyping of blasts in myelodysplasia. Leuk Lymphoma. 1994;15:65–9.
   PubMed Web of Science ®Google Scholar
• Oertel J, Kleiner S, Huhn D. Immunotyping of blasts in refractory anemia with excess of blasts. Br J Haematol. 1993;84:305–9.
   PubMed Web of Science ®Google Scholar
• Oertel J, Oertel B, Beyer J, Huhn D. CD34 immunotyping of blasts in myelodysplasia. Ann Hematol. 1994;68:77–80.
   PubMed Web of Science ®Google Scholar
• Zou P, Yoshihara H, Hosokawa K, Tai I, Shinmyozu K, Tsukahara F, et al.. p57 (Kip2) and p27 (Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell. 2011;9:247–61.
   PubMed Web of Science ®Google Scholar
• Brakensiek K, Länger F, Kreipe H, Lehmann U. Absence of p21 (CIP 1), p27 (KIP 1) and p 57(KIP 2) methylation in MDS and AML. Leuk Res. 2005;29:1357–60.
   PubMed Web of Science ®Google Scholar
• Hatzimichael E, Dasoula A, Benetatos L. The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms. Br J Haematol. 2008;141:557–8.
   PubMed Web of Science ®Google Scholar
• Umemoto T, Yamato M, Nishida K, Yang J, Tano Y, Okano T. p57kip2Kip2 is expressed in quiescent mouse bone marrow side population cells. Biochem Biophys Res Commun. 2005;337:14–21.
   PubMed Web of Science ®Google Scholar
• Matsuda M, Morita Y, Hanamoto H, Tatsumi Y, Maeda Y, Kanamaru A. CD34+ Progenitors from MDS patients are unresponsive to SDF-1, despite high levels of SDF-1 in bone marrow plasma. Leukemia. 2004;18:1038–40.
   PubMed Web of Science ®Google Scholar
• Fuhler GM, Drayer AL, Olthof SG, Schuringa JJ, Coffer PJ, Vellenga E. Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell-derived factor-1 induced migration of CD34+ cells from patients with myelodysplasia. Blood. 2008;111:359–68.
   PubMed Web of Science ®Google Scholar
• Fuhler GM, Drayer AL, Vellenga E. Decreased phosphorylation of protein kinase B and extracellular signal-regulated kinase in neutrophils from patients with myelodysplasia. Blood. 2003;101:1172–80.
   PubMed Web of Science ®Google Scholar